| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/13/1985 | EP0134111A1 Araliphatic sulphides,sulphones and sulphoxides and their pharmaceutical use |
| 03/13/1985 | EP0133988A2 Regulating peptide-containing pharmaceutical preparations with retarded release, and process for their preparation |
| 03/12/1985 | US4504644 Sunscreen agents |
| 03/12/1985 | US4504587 Complexing labeled mixture with antibodies and quantifying antigen-antibody complex |
| 03/12/1985 | US4504584 Cultures of novel strains of Streptomyces |
| 03/12/1985 | US4504471 Animal growth promotant and method of use for animal growth |
| 03/12/1985 | US4504470 Pharmaceutical preparations containing TRH or its analogue |
| 03/12/1985 | US4504469 Vasotocin derivatives |
| 03/12/1985 | US4504467 Antibiotics, oxidative deamination, feeds |
| 03/12/1985 | US4504415 Synthesis of thymosin α1 and desacetyl thymosin α1 |
| 03/12/1985 | US4504414 Synthetic pyridyl-alanyl decapeptides having antiovulatory activity |
| 03/12/1985 | CA1183836A1 Dihydrobenzofuranyl derivatives of ala-pro |
| 03/12/1985 | CA1183776A1 Collagen implant containing active ingredient(s) for implantation in bones or soft tissues and process for its manufacture |
| 03/06/1985 | EP0133767A2 Gamma interferon composition |
| 03/05/1985 | US4503044 Peptide antibiotics, bactericides, antitumor agents |
| 03/05/1985 | US4503043 Hypotensives |
| 03/05/1985 | US4503039 Coagulant plasma-protein solution |
| 03/05/1985 | US4503038 Extracellular nonmitogenic angiogenesis factor and method of isolation thereof from wound fluid |
| 03/05/1985 | CA1183526A1 Oligopeptides with specific inhibiting properties of collagen induced aggregation, process for preparing the same and pharmaceutical compositions containing them |
| 03/05/1985 | CA1183478A1 Method for the production of improved chymopapain |
| 03/05/1985 | CA1183470A1 Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, and methods |
| 03/05/1985 | CA1183469A1 Hybrid cell line for producing complement-fixing monoclonal antibody to human suppressor t cells, antibody, and method |
| 03/05/1985 | CA1183451A1 Method for producing a csap tryptic peptide and anti- csap antibodies |
| 02/28/1985 | WO1985000831A1 Microbial expression of insulin-like growth factor |
| 02/28/1985 | WO1985000830A1 Process for producing human interleukine 1 and related drugs |
| 02/28/1985 | WO1985000812A1 Conjugates of proteins with anti-tumour agents |
| 02/28/1985 | WO1985000810A1 Fused 7-membered ring compounds and process for their preparation |
| 02/28/1985 | WO1985000750A1 Hybridoma cell line producing suppressive factor of allergy |
| 02/28/1985 | WO1985000749A1 Improvements in or relating to immunological compositions |
| 02/28/1985 | EP0107710A4 The manufacture and expression of genes for calcitonin and polypeptide analogs thereof. |
| 02/27/1985 | EP0133551A2 Monoclonal antibody which recognizes a structure which is common to the human interleukin-2 (TCGF) and to the light chain lambda of human immunoglobulin, and hybridoma cell lines producing this monoclonal antibody |
| 02/27/1985 | EP0133438A1 Enzyme ointment |
| 02/26/1985 | US4501733 Analgesics, antiinflammatory and antispasmodic agents |
| 02/26/1985 | US4501731 Treatment of disparate bleeding disorders with factor X zymogen |
| 02/26/1985 | US4501693 Hydrolyzing proteoglycans with lysozyme |
| 02/26/1985 | CA1183140A1 Process for preparing carboxylic azo-bicyclo-octane acids |
| 02/26/1985 | CA1183130A1 L-argininal derivatives and a method of manufacturing the same |
| 02/26/1985 | CA1183129A1 Lipophilic muramyl peptides and processes for their manufacture |
| 02/26/1985 | CA1183128A1 Muramyldipeptide derivatives |
| 02/26/1985 | CA1183127A1 Process for the preparation of derivatives of cyclic peptide nuclei |
| 02/20/1985 | EP0133358A2 Processes for the production of agents for inhibiting the proliferation of malignant tumour cells, and agents produced thereby |
| 02/20/1985 | EP0133308A2 Agent for controlling the appetite and process for its preparation |
| 02/20/1985 | EP0133285A1 Crystal suspensions of insulin derivatives, process for their preparation and their use |
| 02/20/1985 | EP0133284A2 Process for isolating and purifying interferon |
| 02/20/1985 | EP0133225A2 Peptide derivatives and their salts, pharmaceutical preparations containing them, process and intermediates for their production |
| 02/20/1985 | EP0051071B1 Tryptophane derivative and process for preparing same |
| 02/19/1985 | US4500713 Therapeutic dipeptides |
| 02/19/1985 | US4500637 Prevention of graft versus host disease following bone marrow transplantation |
| 02/19/1985 | US4500518 Amino thiol dipeptides |
| 02/19/1985 | US4500514 Addition of sodium or potassium citrate |
| 02/19/1985 | US4500467 Benzoylthio compounds, their preparation and their use as drugs |
| 02/19/1985 | US4500451 New protein PP13 extracted from human placental tissues and use thereof |
| 02/19/1985 | US4500450 Polypeptide having an action on the immunological system, process for its isolation and purification, its use, agents containing this compound, and its cleavage products, their use and agents containing these products |
| 02/19/1985 | CA1182812A1 Process for the preparation of derivatives of cyclic peptide nuclei |
| 02/19/1985 | CA1182811A1 Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for its obtention and its applications |
| 02/19/1985 | CA1182748A1 Method for synthesizing procoagulant factor viii activity |
| 02/19/1985 | CA1182747A1 Elastase-containing composition permitting elastase to be absorbed in increased amount |
| 02/14/1985 | WO1985000606A1 Human il-2 and process for its preparation |
| 02/14/1985 | WO1985000597A1 Insulin-potentiating peptides |
| 02/14/1985 | WO1985000521A1 Enzyme derivatives |
| 02/13/1985 | EP0133098A1 Synergistin derivatives and their preparation |
| 02/13/1985 | EP0133097A1 Synergistin derivatives, their preparation and pharmaceutical compositions thereof |
| 02/13/1985 | EP0133096A1 Synergistin derivatives, their preparation and pharmaceutical compositions thereof |
| 02/13/1985 | EP0133029A2 A process for producing inhibiting agents against proliferation of malignant tumour cells, and agents produced thereby |
| 02/13/1985 | EP0132979A2 Aqueous atelocollagen solution and method of preparing same |
| 02/13/1985 | EP0132919A1 Peptides |
| 02/13/1985 | EP0132770A1 Insulin derivatives, processes for their preparation, their use and pharmaceutical compositions for the treatment of diabetes mellitus |
| 02/13/1985 | EP0132769A1 Pharmaceutical formulation for the treatment of diabetes mellitus |
| 02/13/1985 | EP0132754A2 Use of gamma-interferon in the manufacture of a medicament for the treatment of leprosy |
| 02/13/1985 | EP0132732A2 Homologues from aprotinine whose lys 15 amino acid is substituted by other amino acids, process for their preparation and their use as medicaments |
| 02/12/1985 | US4499102 Hypotensive and antidiabetic agents |
| 02/12/1985 | US4499093 Administering dipyridamole |
| 02/12/1985 | US4499082 α-Aminoboronic acid peptides |
| 02/12/1985 | US4499081 Inhibits myelopoietic system of humans and animals |
| 02/12/1985 | US4499080 Synthetic ST toxin, process for its preparation and its use as a vaccinating agent |
| 02/12/1985 | US4499079 Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides |
| 02/12/1985 | US4499076 Amino acids, carbohydrates fats, vitamins and minerals |
| 02/12/1985 | US4499072 Process for treating diseases with ODC inhibitors |
| 02/12/1985 | US4499065 Deactivation by blocking thio groups with an iodo- or bromoacetic acid or derivative; desensitization |
| 02/12/1985 | US4499014 Method for purifying gamma-interferon |
| 02/12/1985 | US4498485 Medicating smokable tobacco |
| 02/12/1985 | CA1182448A1 Peptides and a process for their preparation |
| 02/12/1985 | CA1182447A1 Derivatives of actaplanin |
| 02/12/1985 | CA1182444A1 Method of accelerating the dissolution of a hard- soluble lyophilized medicament using a magnetic stirrer |
| 02/12/1985 | CA1182406A1 Hybrid cell line for producing complement-fixing monoclonal antibody to human t cells, antibody, and methods |
| 02/06/1985 | EP0132441A1 Antibacterial peptides |
| 02/05/1985 | US4498193 Jammer transmitter |
| 02/05/1985 | US4497802 Antibiotics; animal growth and improved milk production in lactating ruminants |
| 02/05/1985 | US4497801 Bactericides, viricides |
| 02/05/1985 | US4497799 Polypeptide carcinostatic agent |
| 02/05/1985 | US4497795 Method of regulating appetite and efficiency of food utilization employing interferon |
| 02/05/1985 | US4497732 1A-Endo-glycine-calcitonin |
| 02/05/1985 | US4497731 Hormones |
| 02/05/1985 | US4497729 Bactericides, fungicides |
| 02/05/1985 | CA1182111A1 D-phenylalanyl-l-propyl-l-arginine aldehyde sulfate and process for the preparation thereof |
| 02/05/1985 | CA1182109A1 Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use |
| 02/05/1985 | CA1182061A1 Superoxide dismutase, its production and use |
| 02/05/1985 | CA1182047A1 Process for the production of blood-clotting factors and preparation of factors ix and x, prepared by this process |
| 02/05/1985 | CA1182046A1 Pharmaceutical composition for the treatment of diabetes mellitus |
| 01/31/1985 | WO1985000372A1 Biodegradable polypeptide and utilization thereof for the progressive release of drugs |